Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma

INTRODUCTION: Although the recommended optimal treatment of glioblastoma multiforme (GBM) is adjuvant chemoradiotherapy, trials in GBM have excluded patients older than 70 years. In this study, we aimed to assess overall survival (OS) and prognostic factors in elderly patients (≥ 70 years) with newl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Contemp Oncol (Pozn)
Egile Nagusiak: Metcalfe, Evrim, Karaoglanoglu, Ozden, Akyazici, Emine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Termedia Publishing House 2016
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013689/
https://ncbi.nlm.nih.gov/pubmed/27647990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.61569
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak